Related content

Evaluation of toxicity and single-dose pharmacokinetics of intravenous ursolic acid liposomes in healthy adult volunteers and patients with advanced solid tumors

By Wang Xian-Huo   Zhou Shi-Yong   Qian Zheng-Zi   Zhang Hui-Lai   Qiu Li-Hua   Song Zheng   Zhao Jing   Wang Ping   Hao Xi-Shan   Wang Hua-Qing  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 2, 2013-02 ,pp. : 117-125

Informa Healthcare

Access to resources Recommend Favorite

Phase I dose escalation study of pegylated liposomal doxorubicin (Caelyx^®) in combination with topotecan in patients with advanced malignancies

By Ghesquières Hervé   Faivre Sandrine   Djafari Latifa   Pautier Patricia   Lhommé Catherine   Lozahic Stéphanie   Djazouli Kamel   Armand Jean-Pierre   Raymond Eric  

Investigational New Drugs, Vol. 24, Iss. 5, 2006-09 ,pp. : 413-421

Springer Publishing Company

Access to resources Recommend Favorite

Pathway-based pharmacogenomics of gemcitabine pharmacokinetics in patients with solid tumors

By Mitra Amit K   Kirstein Mark N   Khatri Amit   Skubitz Keith M   Dudek Arkadiusz Z   Greeno Edward W   Kratzke Robert A   Lamba Jatinder K  

Pharmacogenomics, Vol. 13, Iss. 9, 2012-07 ,pp. : 1009-1021

Future Medicine

Access to resources Recommend Favorite

Pharmacokinetics of Pegylated Liposomal Doxorubicin: Review of Animal and Human Studies

By Gabizon A.   Shmeeda H.  

Clinical Pharmacokinetics, Vol. 42, Iss. 5, 2003-01 ,pp. : 419-436

Adis International

Access to resources Recommend Favorite

Activity of weekly irinotecan (CPT-11) in patients with advanced non-small cell lung cancer pretreated with platinum and taxanes

By Sánchez Rosa   Esteban Emilio   Palacio Isabel   Fernández Yolanda   Muñiz Isabel   Vieitez Jose M.   Fra Joaquin   Blay Pilar   Villanueva Noemí   Uña Esther   Mareque Beatriz   Estrada Enrique   Buesa Jose M.   Lacave Angel J.  

Investigational New Drugs, Vol. 21, Iss. 4, 2003-11 ,pp. : 459-463

Springer Publishing Company

Access to resources Recommend Favorite